244 related articles for article (PubMed ID: 8628313)
1. Spi-1/PU.1 transgenic mice develop multistep erythroleukemias.
Moreau-Gachelin F; Wendling F; Molina T; Denis N; Titeux M; Grimber G; Briand P; Vainchenker W; Tavitian A
Mol Cell Biol; 1996 May; 16(5):2453-63. PubMed ID: 8628313
[TBL] [Abstract][Full Text] [Related]
2. Germ-line deletion of p53 reveals a multistage tumor progression in spi-1/PU.1 transgenic proerythroblasts.
Scolan EL; Wendling F; Barnache S; Denis N; Tulliez M; Vainchenker W; Moreau-Gachelin F
Oncogene; 2001 Sep; 20(39):5484-92. PubMed ID: 11571646
[TBL] [Abstract][Full Text] [Related]
3. Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines.
Starck J; Doubeikovski A; Sarrazin S; Gonnet C; Rao G; Skoultchi A; Godet J; Dusanter-Fourt I; Morle F
Mol Cell Biol; 1999 Jan; 19(1):121-35. PubMed ID: 9858537
[TBL] [Abstract][Full Text] [Related]
4. Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis.
Galson DL; Hensold JO; Bishop TR; Schalling M; D'Andrea AD; Jones C; Auron PE; Housman DE
Mol Cell Biol; 1993 May; 13(5):2929-41. PubMed ID: 8474451
[TBL] [Abstract][Full Text] [Related]
5. Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation.
Barnache S; Wendling F; Lacombe C; Denis N; Titeux M; Vainchenker W; Moreau-Gachelin F
Oncogene; 1998 Jun; 16(23):2989-95. PubMed ID: 9662331
[TBL] [Abstract][Full Text] [Related]
6. Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation.
Rimmelé P; Kosmider O; Mayeux P; Moreau-Gachelin F; Guillouf C
Blood; 2007 Apr; 109(7):3007-14. PubMed ID: 17132716
[TBL] [Abstract][Full Text] [Related]
7. Multiple functional domains of the oncoproteins Spi-1/PU.1 and TLS are involved in their opposite splicing effects in erythroleukemic cells.
Delva L; Gallais I; Guillouf C; Denis N; Orvain C; Moreau-Gachelin F
Oncogene; 2004 May; 23(25):4389-99. PubMed ID: 15064749
[TBL] [Abstract][Full Text] [Related]
8. Spi-1 oncogene activation in Rauscher and Friend murine virus-induced acute erythroleukemias.
Moreau-Gachelin F; Ray D; de Both NJ; van der Feltz MJ; Tambourin P; Tavitian A
Leukemia; 1990 Jan; 4(1):20-3. PubMed ID: 2153262
[TBL] [Abstract][Full Text] [Related]
9. The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias.
Moreau-Gachelin F; Ray D; Mattei MG; Tambourin P; Tavitian A
Oncogene; 1989 Dec; 4(12):1449-56. PubMed ID: 2594367
[TBL] [Abstract][Full Text] [Related]
10. Fli-1 overexpression in erythroleukemic cells promotes erythroid de-differentiation while Spi-1/PU.1 exerts the opposite effect.
Vecchiarelli-Federico LM; Liu T; Yao Y; Gao Y; Li Y; Li YJ; Ben-David Y
Int J Oncol; 2017 Aug; 51(2):456-466. PubMed ID: 28586009
[TBL] [Abstract][Full Text] [Related]
11. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
[TBL] [Abstract][Full Text] [Related]
12. Expression of the transcription factor, Spi-1 (PU.1), in differentiating murine erythroleukemia cells Is regulated post-transcriptionally. Evidence for differential stability of transcription factor mRNAs following inducer exposure.
Hensold JO; Stratton CA; Barth D; Galson DL
J Biol Chem; 1996 Feb; 271(7):3385-91. PubMed ID: 8631937
[TBL] [Abstract][Full Text] [Related]
13. Retroviral insertional activation of the Fli-3 locus in erythroleukemias encoding a cluster of microRNAs that convert Epo-induced differentiation to proliferation.
Cui JW; Li YJ; Sarkar A; Brown J; Tan YH; Premyslova M; Michaud C; Iscove N; Wang GJ; Ben-David Y
Blood; 2007 Oct; 110(7):2631-40. PubMed ID: 17586726
[TBL] [Abstract][Full Text] [Related]
14. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of Friend leukemia virus.
Ikawa Y
Leukemia; 1997 Apr; 11 Suppl 3():152-4. PubMed ID: 9209327
[TBL] [Abstract][Full Text] [Related]
16. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor Spi-1/PU.1 binds RNA and interferes with the RNA-binding protein p54nrb.
Hallier M; Tavitian A; Moreau-Gachelin F
J Biol Chem; 1996 May; 271(19):11177-81. PubMed ID: 8626664
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblasts.
Barnache S; Mayeux P; Payrastre B; Moreau-Gachelin F
Blood; 2001 Oct; 98(8):2372-81. PubMed ID: 11588033
[TBL] [Abstract][Full Text] [Related]
19. Erythroleukaemia induction by the Friend spleen focus-forming virus.
Ruscetti SK
Baillieres Clin Haematol; 1995 Mar; 8(1):225-47. PubMed ID: 7663048
[TBL] [Abstract][Full Text] [Related]
20. Subtle distinct regulations of late erythroid molecular events by PI3K/AKT-mediated activation of Spi-1/PU.1 oncogene autoregulation loop.
Breig O; Théoleyre O; Douablin A; Baklouti F
Oncogene; 2010 May; 29(19):2807-16. PubMed ID: 20190819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
